483 Mylan Pharmaceuticals Sep 2012

483 Mylan Pharmaceuticals Sep 2012

Mark Chan FDA, Lance De Souza FDA$119.00 - Available Now

FDA investigators audited the Mylan Pharmaceuticals - San Carlos, CA, United States facility and issued inspectional observations (via FDA 483) on 27 Sep 2012.

Product details

  • Category: Human Drugs / Medical Devices & Rad Health
  • Inspection end: 27 Sep 2012
  • Location: San Carlos, United States
  • FEI: 3007886374
Add To Cart